School of Pharmacy Publications

Browse Results (3364 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 44 of 68

Result Pages:    « first ‹ previous  34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53  next › last »

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Whitty J.A., Stewart S., Carrington M.J., Calderone A., Marwick T., Horowitz J.D., Krum H., Davidson P.M., Macdonald P.S., Reid C. and Scuffham P.A. (2013) Patient Preferences and Willingness-To-Pay for a Home or Clinic Based Program of Chronic Heart Failure Management: Findings from the Which? Trial. PLoS ONE, 8 3: e58347.1-e58347.8. doi:10.1371/journal.pone.0058347 41   2 Cited 4 times in Scopus4 0
Sweeting, Kent R., Whitty, Jennifer A., Scuffham, Paul A. and Yelland, Michael J. (2011) Patient preferences for treatment of achilles tendon pain: results from a discrete-choice experiment. Patient, 4 1: 45-54. doi:10.2165/11532830-000000000-00000 20   4 Cited 3 times in Scopus3 0
Sim, Lily, Barras, Michael and Cottrell, Neil (2005) Patients' understanding of drug allergy and documentation: Is there a link?. Journal of Pharmacy Practice and Research, 35 4: 276-278. 177   Cited 3 times in Scopus3
Gerard, Karen, Tinelli, Michela, Latter, Sue, Smith, Alesha and Blenkinsopp, Alison (2014) Patients' valuation of the prescribing nurse in primary care: a discrete choice experiment. Health Expectations, 1-13. doi:10.1111/hex.12193 12   Cited 0 times in Scopus0 22
Yates, Patsy M., Beadle, Geoffrey F., Clavarino, A., Najman, Jake M., Thomson, Damien, Williams, Gail, Kenny, Lisbeth, Roberts, Sydney, Mason, Bernard and Schlect, David (1993) Patients with terminal cancer who use alternative therapies: their beliefs and practices. Sociology of Health and Illness, 15 2: 199-216. doi:10.1111/1467-9566.ep11346886 92   51 0
Duley, J. A. (2005) Patrons and Riders : Conflicting roles and hidden objectives in an Aboriginal development program (Book Review). Australian Journal of Adult Learning, 44 119-123. 48  
Chan, V. and Tett, S.E. (2003). Pattern of disease modifying anti-rheumatic drug utilisation in Australia 1992-2002. In: Integrating research into practice. Annual Conference of APSA 2003, Bondi Beach, NSW, (3-3). 3-5 Dec. 2003. 33  
Staatz, Christine E., Smith, Alesha and Tett, Susan E. (2008). Pattern of mycophenolate prescribing in Australian kidney and cardiac transplant recipients. In: National Medicines Symposium 2008, Canberra, (). 14-16 May 2008. 39  
Hollingworth, Samantha A., Siskind, Dan J., Nissen, Lisa M., Robinson, Maxine and Hall, Wayne D. (2010) Patterns of antipsychotic medication use in Australia 2002-2007. Australian And New Zealand Journal of Psychiatry, 44 4: 372-377. doi:10.3109/00048670903489890 314   23 Cited 26 times in Scopus26 6
Bose, Utpal, Hodson, Mark P., Vidgen, Miranda E., Shaw, P. Nicholas, Fuerst, John A. and Hewavitharana, Amitha K. (2013). Patterns of chemical diversity on sponge associated marine bacteria. In: 9th Annual Conference of the Metabolomics Society: Full Abstracts. 9th Annual Conference of the Metabolomics Society, Glasgow, Scotland, U.K., (264-264). 1-4 July, 2013. 34  
Peeters, G., Tett, S. E., Duncan, E. L., Mishra, G. D. and Dobson, A. J. (2013). Patterns of Osteoporosis Medication Dispensing for Older Australian Women From 2002 to 2010: Influences of Publications, Guidelines, Marketing Activities and Policy. In: Annual European Congress of Rheumatology EULAR abstracts. EULAR 2013, Madrid, Spain, (294-294). 12 - 15 June 2013. doi:10.1136/annrheumdis-2013-eular.908 28   0 0
Dulla B., Kolli S.K., Chamakura U.R., Deora G.S., Raju R.R. and Pal M. (2014) Pd/C-mediated arylation followed by I2-catalyzed hydration strategy: Preparation of functionalized novel indanone derivatives. Synthetic Communications, 44 10: 1466-1474. doi:10.1080/00397911.2013.860554 25   1 Cited 1 times in Scopus1 0
Lum, E. P. M., La Caze, A. and Cutts, C. (2003). Peer group teleconferences: A rural strategy for enhancing quality prescribing?. In: 26th Federal Conference program handbook. SHPA 26th Federal Conference 2003, Canberra, (159-159). 13-16 Nov. 2003. 22  
Robinson, M. T. (2005) Pegatron: (Combination product of peginterferon (a2b) in a pen injector and ribavirin capsules). The New Drug Brief, 23 Aug. 1-5. 61  
Faridoon, Hussein, Waleed M., Islam, Nazar Ul, Guddat, Luke W., Schenk, Gerhard and McGeary, Ross P. (2012) Penicillin inhibitors of purple acid phosphatase. Bioorganic and Medicinal Chemistry Letters, 22 7: 2555-2559. doi:10.1016/j.bmcl.2012.01.123 58   0 Cited 1 times in Scopus1 0
Khan, Saad A., Moorthy, Jayanthy, Omar, Hanan and Hasan, Syed Shahzad (2012) People living with HIV/AIDS (PLWHA) and HIV/AIDS associated oral lesions; a study in Malaysia. Bmc Public Health, 12 1: 850-1-850-8. doi:10.1186/1471-2458-12-850 32   1 Cited 2 times in Scopus2 1
Hunter, A. (2006) Peppermint: how cool is that?. Australian Pharmacist, 25 1: 50-50. 38  
Skwarczynski, Mariusz, Dougall, Annette M., Khoshnejad, Makan, Chandrudu, Saranya, Pearson, Mark S., Loukas, Alex and Toth, Istvan (2012) Peptide-Based Subunit Vaccine against Hookworm Infection. PLoS One, 7 10 Article #e46870: . doi:10.1371/journal.pone.0046870 47   8 Cited 10 times in Scopus10 0
Ahmad Fuaad, Abdullah A. H., Azmi, Fazren, Skwarczynski, Mariusz and Toth, Istvan (2013) Peptide conjugation via CuAAC 'click' chemistry. Molecules, 18 11: 13148-13174. doi:10.3390/molecules181113148 38   8 Cited 10 times in Scopus10 0
Goodwin, D., Simerska, P. and Toth, I. (2012) Peptides as therapeutics with enhanced bioactivity. Current Medicinal Chemistry, 19 26: 4451-4461. doi:10.2174/092986712803251548 66 2 16 Cited 22 times in Scopus22 0
Barozzi, N. and Tett, S.E. (2007). Perceived barriers to acetaminophen prescribing, especially following rofecoxib withdrawal from the market. In: Abstracts : Fourth Canadian Therapeutics Congress. 4th Canadian Therapeutics Congress, Halifax, Nova Scotia, Canada, (e152-e152). 27-30 May 2007. 21  
Barozzi, N. and Tett, S. E. (2009) Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market. Clinical Rheumatology, 28 5: 509-519. doi:10.1007/s10067-008-1077-8 61   4 Cited 7 times in Scopus7 0
Hasan, Syed Shahzad, Wong. Pei Se, Ahmed, Syed Imran, Chong, David Weng Kwai, Mai, Chun Wai, Pook, Peter and Kairuz, Therese (2013) Perceived impact of clinical placements on students' preparedness to provide patient-centered care in Malaysia. Currents in Pharmacy Teaching and Learning, 5 4: 303-310. doi:10.1016/j.cptl.2013.01.010 58   Cited 0 times in Scopus0 0
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2008) Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews. Clinical Therapeutics, 30 12: 2461-2473. doi:10.1016/j.clinthera.2008.12.016 106   8 Cited 8 times in Scopus8 0
Babar, Muneer Gohar, Syed, Shahzad Hasan, Naing, Cho Min and Hamzah, Nur Hidayah Binti (2012) Perceptions and self-use of Complementary and Alternative Medicine (CAM) among Malaysian dental students. European Journal of Integrative Medicine, 4 1: E63-E69. doi:10.1016/j.eujim.2011.11.001 36   0 Cited 2 times in Scopus2 0
Bajramovic, Jasmina, Emmerton, Lynne and Tett, Susan E. (2004) Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expectations, 7 3: 221-234. doi:10.1111/j.1369-7625.2004.00280.x 146   22 Cited 32 times in Scopus32 0
Bajramovic Fejzic, J., Emmerton, L. M. and Tett, S. E. (2004). Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. In: Maria Cordina, Social Pharmacy: Exploring theoretical and cultural perspectives. 13th International Social Pharmacy Workshop, Malta, (64-64). 19-23 July, 2004. 60  
Kairuz, Therese, Case, Sarah and Shaw, John (2007) Perceptions of graduates and preceptors regarding a new pharmacy programme. Pharmacy Education, 7 2: 151-157. doi:10.1080/15602210701275864 32   Cited 5 times in Scopus5 0
Cottrell, N., Emmerton, L. and Denaro, C. (2010). Perceptions of heart failure patients towards non-steroidal anti-inflammatory drugs. In: Abstract of the National Medicines Sympsium 2010: Medicines in people‚Äôs lives.. National Medicines Symposium 2010, Melbourne, VIC, Australia, (235-235). 26-28 May, 2010. 39  
Hall, Kristine B., Tett, Susan E. and Nissen, Lisa M. (2006) Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Medical Care, 44 4: 383-387. doi:10.1097/01.mlr.0000204017.71426.53 153   20 Cited 21 times in Scopus21 0
Monteith, G. R. (1999) Performance enhancing drugs. Australian Pharmacist, 18 11: 654-658. 81  
Charles, B. G., Hussein, R., Morris, R.G. and Rasiah, R. L. (2001). Perhexiline population pharmacokinetics in refractory angina patients. In: K. Brosen, O.A. Medergaard and M. Orme, Clinical pharmacology - from molecule to society - bridging the gap via man. 5th Congress of European Assoc. for Clinical Pharmacology &Therapeutics, Odense, Denmark, (83-83). 12-15 Sept 2001. 88  
Charles, B. G., Hussein, R., Morris, R.G. and Rasiah, R. L. (2001). Perhexiline population pharmacokinetics in refractory angina using retrospective routine therapeutic drug monitoring data. In: S.J. Soldin and F. Sjoqvist, Abstracts - 7th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology. 7th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Washington DC, (493-493). 1-6 Sept 2001. 68  
Steer, P., Flenady, V., Gray, P., Shearman, A. D. and Charles, B. G. (2000). Periextubation caffeine for neonates born less than 30 weeks gestation: a randomised trial of two dosing regimens. In: Proceedings of 4th annual congress of Perinatal Society of Australia & New Zealand. 4th Annual Congress of PSANZ, Brisbane, Qld, Australia, (75-75). 12-15 March 2000. 66  
Steer, P.A., Flenady, V.J., Gray, P.H., Shearman, A.D., Henderson-Smart, D., Fraser, S., Bury, G. and Charles, B.G. (2000). Periextubation caffeine in neonates born less than 30 weeks gestation: A randomised trial of two dosing regimens. In: Unknown. Unknown, Unknown, (434A-434A). Unknown. 27   0
Steer, P. A., Flenady, V. J., Shearman, A., Lee, T. C., Tudehope, D. I. and Charles, B. G. (2003) Periextubation caffeine in preterm neonates: A randomized dose response trial. Journal of Paediatrics And Child Health, 39 7: 511-515. doi:10.1046/j.1440-1754.2003.00207.x 113   12 Cited 15 times in Scopus15 0
Hale, A. R., Coombes, I. D., Stokes, J., McDougall, D., Whitfield, K., Maycock, E. and Nissen, L. (2013) Perioperative medication management: Expanding the role of the preadmission clinic pharmacist in a single centre, randomised controlled trial of collaborative prescribing. BMJ Open, 3 7: . doi:10.1136/bmjopen-2013-003027 22   1 Cited 4 times in Scopus4 23
Varamini, Pegah, Goh, Wei Huang, Mansfeld, Friederike M., Blanchfield, Joanne T., Wyse, Bruce D., Smith, Maree T. and Toth, Istvan (2013) Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipation. Bioorganic & Medicinal Chemistry, 21 7: 1898-1904. doi:10.1016/j.bmc.2013.01.044 61   6 Cited 6 times in Scopus6 0
Faddy, H. M., Robinson, J. A., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2004). Peroxisome proliferator-activated receptor a in human breast cancer cell lines. In: Building a healthier future through research. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, (264-264). 30 November - 1 December, 2004. 51  
Suchanek, K. M., Lee, W. J., May, F. J., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2001). Peroxisome proliferator-activated receptor alpha and beta characterization in human mammary gland epithelial cell lines. In: International Congress of Toxicology, Brisbane Australia, (93-93). 8-13 July 2001. 46   0
Faddy, H. M., Robinson, J. A., Lee, W. J., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2006) Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate. International Journal of Biochemistry & Cell Biology, 38 2: 255-266. doi:10.1016/j.biocel.2005.09.002 77   14 Cited 12 times in Scopus12 0
Suchanek, Kate M., May, Fiona J., Robinson, Jodie A., Lee, Won Jae, Holman, Nicola A., Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2002) Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Molecular Carcinogenesis, 34 4: 165-171. doi:10.1002/mc.10061 83   71 Cited 75 times in Scopus75 0
Jeffery, B, Choudhury, AI, Horley, N, Bruce, M, Tomlinson, SR, Roberts, RA, Gray, TJB, Barrett, DA, Shaw, PN, Kendall, D and Bell, DR (2004) Peroxisome proliferator activated receptor alpha regulates a male-specific cytochrome P450 in mouse liver. Archives of Biochemistry And Biophysics, 429 2: 231-236. doi:10.1016/j.abb.2004.06.025 75   11 Cited 10 times in Scopus10 0
Suchanek, K. M., May, F. J., Lee, W. J., Holman, N. A. and Roberts-Thomson, S. J. (2002) Peroxisome proliferator-activated receptor beta expression in human breast epithelial cell lines of tumorigenic and non-tumorigenic origin. International Journal of Biochemistry & Cell Biology, 34 9: 1051-1058. doi:10.1016/S1357-2725(02)00025-0 51   26 Cited 25 times in Scopus25 0
Falconer, Caitlin, Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2009). Peroxisome proliferator-activated receptor expression in the mouse mammary gland and human breast cancer cell lines. In: ASCEPT 43rd Annual Scientific Meeting 2009: The Rights of Medicines, Darling Harbour, NSW, Australia, (). 29 November-2 December 2009. 27  
Peiris, M., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Peroxisome-proliferator activated receptor (PPAR) beta/delta and its role inr elapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE). In: Neuroscience 2006. Neuroscience 2006, Georgia World Congress Center / Altana, Georgia, U.S.A., (). 11-18 October, 2006. 79  
Lister, E. J., Faddy, H. M., Aung, C. S., Monteith, G. R. and Roberts-Thomson, S. J. (2005). Peroxisome proliferator activated receptor (PPAR) isoform expression during differentiation of HT-29 colon cancer cells. In: E. A. Davis and C. G. Sobey, Program & Abstracts: Joint Meeting of ASCEPT and APSA 2005. Joint Meeting of ASCEPT and APSA, Melbourne, Vic, Australia, (1-79-1-79). 4-7 December, 2005. 65  
Smith, S. A., Monteith, G. R. and Roberts-Thomson, S. J. (2002). Peroxisome proliferator-activated receptors in rat cerebellar granule neuronal cultures. In: Proceedings of the Society for Neuroscience 2002. Neuroscience 2002, Florida, (493-493). 2-7 Nov. 2002. 46  
Roberts-Thomson, S. J. (2000) Peroxisome proliferator-activated receptors in tumorigenesis: Targets of tumour promotion and treatment. Immunology And Cell Biology, 78 4: 436-441. doi:10.1046/j.1440-1711.2000.00921.x 58   59 Cited 67 times in Scopus67 0
Peiris, M., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Peroxisome-proliferator activated receptors modulate inflammation in relapsing-remitting experimental autoimmune encephalomyelitis. In: Combined Conference Abstracts: ComBio 2006. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, (178-178). 24-28 September, 2006. 52  

Page 44 of 68

Result Pages:    « first ‹ previous  34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53  next › last »